Valley Wealth Managers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-454
| Closed | -$226K | – | 376 |
|
2025
Q1 | $226K | Hold |
454
| – | – | 0.02% | 171 |
|
2024
Q4 | $236K | Hold |
454
| – | – | 0.02% | 176 |
|
2024
Q3 | $281K | Sell |
454
-213
| -32% | -$132K | 0.02% | 176 |
|
2024
Q2 | $369K | Sell |
667
-5
| -0.7% | -$2.77K | 0.03% | 168 |
|
2024
Q1 | $391K | Sell |
672
-13
| -2% | -$7.56K | 0.03% | 163 |
|
2023
Q4 | $364K | Buy |
685
+142
| +26% | +$75.4K | 0.03% | 152 |
|
2023
Q3 | $275K | Buy |
543
+16
| +3% | +$8.1K | 0.02% | 169 |
|
2023
Q2 | $275K | Buy |
527
+2
| +0.4% | +$1.04K | 0.02% | 143 |
|
2023
Q1 | $303K | Sell |
525
-1
| -0.2% | -$576 | 0.03% | 134 |
|
2022
Q4 | $290K | Sell |
526
-50
| -9% | -$27.5K | 0.03% | 137 |
|
2022
Q3 | $292K | Hold |
576
| – | – | 0.03% | 139 |
|
2022
Q2 | $313K | Sell |
576
-162
| -22% | -$88K | 0.03% | 147 |
|
2022
Q1 | $436K | Buy |
738
+44
| +6% | +$26K | 0.04% | 132 |
|
2021
Q4 | $463K | Buy |
694
+57
| +9% | +$38K | 0.04% | 134 |
|
2021
Q3 | $364K | Buy |
637
+30
| +5% | +$17.1K | 0.03% | 142 |
|
2021
Q2 | $306K | Buy |
607
+138
| +29% | +$69.6K | 0.03% | 155 |
|
2021
Q1 | $214K | Buy |
+469
| New | +$214K | 0.02% | 158 |
|
2020
Q1 | – | Sell |
-644
| Closed | -$209K | – | 184 |
|
2019
Q4 | $209K | Buy |
+644
| New | +$209K | 0.02% | 180 |
|
2019
Q3 | – | Sell |
-1,372
| Closed | -$403K | – | 202 |
|
2019
Q2 | $403K | Sell |
1,372
-1,391
| -50% | -$409K | 0.04% | 154 |
|
2019
Q1 | $756K | Buy |
2,763
+1,673
| +153% | +$458K | 0.08% | 122 |
|
2018
Q4 | $244K | Buy |
+1,090
| New | +$244K | 0.03% | 152 |
|